People with a buildup of fatty atherosclerotic plaque in the heart's arteries considered at risk of rupturing were far less likely to suffer a serious cardiac event if they underwent percutaneous ...

USA: Researchers have found in a meta-analysis published in the Journal of the American College of Cardiology that ...

Prophylactic mechanical support devices may not reduce cardiovascular risk in patients who undergo complex high-risk stenting procedures.

Aspirin resistance is a major clinical concern that compromises the effectiveness of antiplatelet therapy in patients with Acute Coronary Syndrome (ACS). Genetic polymorphisms, particularly in TBXA2R ...

Percutaneous coronary intervention (PCI) has proven lifesaving: Morbidity and mortality outcomes are significantly improved with PCI when compared to clot-busting therapy. However, not all hospitals ...

Dual antiplatelet therapy (DAPT) is the mainstay treatment following percutaneous coronary intervention (PCI) with drug-eluting stents (DES) to reduce stent thrombosis and target lesion failure.

The Cordis Selution SLR drug-eluting balloon illustrated during a percutaneous coronary intervention. [Illustration courtesy ...

A study from Ahmedabad's UNMICRC highlights that while men experience heart attacks more frequently, women face significantly ...

Monotherapy with a P2Y 12 inhibitor after a minimum period of dual antiplatelet therapy is an emerging approach to reduce the risk of bleeding after percutaneous coronary intervention (PCI). In a ...

There are limited data from randomized trials evaluating the use of antithrombotic therapy in patients with atrial fibrillation and stable coronary artery disease. In a multicenter, open-label trial ...